X4 Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
X4 Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from X4 Pharmaceuticals Inc
Access all reports
X4 Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for rare diseases, particularly those involving immune system dysfunctions. The company leverages its expertise in small-molecule therapeutics to address conditions associated with abnormal white blood cell activity. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for X4 Pharmaceuticals Inc
Q1 2025
X4 Pharmaceuticals Inc
Q3 2024
X4 Pharmaceuticals Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
XFOR
Country
🇺🇸 United States